SCHEMBL16490449

SCHEMBL16490449

CCCNC(=O)Nc1nc(C)c(-c2ccc(C)c(S(=O)(=O)Nc3ccc(O)cc3)c2)s1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 10/20 0.65
PIK3CG P48736 10/20 0.62
PIK3CD O00329 9/20 0.62
PIK3C3 Q8NEB9 4/20 0.62
PIK3CA P42336 7/20 0.59
PIK3C2G O75747 4/20 0.59
PIK3CB P42338 4/20 0.47
CLK1 P49759 1/20 0.46
CLK2 P49760 1/20 0.46
PIK3C2A O00443 1/20 0.45
PIK3C2B O00750 1/20 0.45
PI4KA P42356 1/20 0.45
PRKDC P78527 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14851648 0.90 PI4KB (0.81) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490453 0.89 PI4KB (0.81) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490450 0.88 PIK3CG (0.67) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490596 0.87 PIK3CG (0.66) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490447 0.86 PIK3CG (0.65) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490445 0.85 PI4KB (0.64) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490454 0.85 PIK3CG (0.61) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490446 0.85 PIK3CG (0.63) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490346 0.84 PIK3CD (0.80) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA
SCHEMBL16490386 0.83 PIK3CG (0.66) PI4KBPIK3CGPIK3CDPIK3C3PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9309236-B2 PI-kinase inhibitors with broad spectrum anti-infective activity THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2016-04-12 US disclosed
US-20150051193-A1 PI-kinase Inhibitors with Broad Spectrum Anti-Infective Activity THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2015-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051193-A1 PI-kinase Inhibitors with Broad Spectrum Anti-Infective Activity PIP4K2A, PIP5K1A, PIP4K2C PI4KB 9/4885PIK3CG 22/4885PIK3CD 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.